Esophageal Squamous Cell Carcinoma (ESCC) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033
Esophageal squamous cell carcinoma predominantly manifests in the upper and middle segments of the esophagus and is commonly linked to tobacco use and alcohol consumption. Despite treatments aimed at cure, recurrence frequently manifests in patients. Upon suspicion of recurrence, patients undergo comprehensive evaluations such as PET/CT scans, endoscopic ultrasound, upper endoscopy, biopsy, or other relevant diagnostic techniques tailored to the suspected site of recurrence. The standard therapeutic strategy for locally advanced, operable esophageal squamous cell carcinoma involves chemoradiation (CRT) with or without surgical intervention. For patients with early-stage T1N0 esophageal squamous cell carcinoma, treatment options include surgery, endoscopic resection (either by endoscopic submucosal dissection or endoscopic mucosal resection), or radiation therapy alone, with the treatment approach being customized for each patient. Thelansis’s “Esophageal Squamous Cel...